Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 18Terminated 6Recruiting 6Unknown 5Active not recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 11INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1

Conditions

Ulnar Neuropathies 1Neuroma 1Neoplasms 1Lymphoma, Follicular 1Cubital Tunnel Syndrome 1Constriction, Pathologic 1

Interventions

pembrolizumab 184Carboplatin 132Paclitaxel 101Cisplatin 101Gemcitabine 86Pemetrexed 79durvalumab 75Nivolumab 66Docetaxel 56atezolizumab 52Bevacizumab 50Cyclophosphamide 49Dexamethasone 45Capecitabine 45Oxaliplatin 43130-nm albumin-bound paclitaxel 41Rituximab 40Fulvestrant 39Lenalidomide 38Fluorouracil 38Prednisone 32osimertinib 31olaparib 29Leucovorin 29venetoclax 28fludarabine 28Trastuzumab 27Doxorubicin 27Etoposide 25Cetuximab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × Therapeutics × Clear all
NCT05149755 2026-05-19

Evolutâ„¢ EXPAND TAVR II Pivotal Trial

Medtronic Cardiovascular

Phase NA Active not recruiting
650 enrolled
Lymphoid

Constriction, Pathologic, Lymphoma, Follicular

NCT04662320 2024-12-05

PHONES

Checkpoint Surgical Inc.

Phase NA Active not recruiting
100 enrolled

Neuroma, Ulnar Neuropathies, Cubital Tunnel Syndrome

NCT02193503 2023-09-28

MVX-ONCO-1 in Patients With Solid Tumor

Maxivax SA

Phase 1 Active not recruiting
34 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡